Ferry Ossendorp focuses on Antigen presentation, Cytotoxic T cell, Immunology, Antigen and MHC class I. His Antigen presentation research integrates issues from Epitope, Molecular biology, CTL* and Cell biology. His study in Cytotoxic T cell is interdisciplinary in nature, drawing from both Dendritic cell, CD8, Major histocompatibility complex and T helper cell.
His study in Immunology focuses on T cell, Immune system and Vaccination. His Vaccination research is multidisciplinary, incorporating elements of Cancer and Disease. Ferry Ossendorp works mostly in the field of Antigen, limiting it down to concerns involving Internalization and, occasionally, In vitro.
His primary scientific interests are in Antigen, Immunology, Cytotoxic T cell, Immune system and T cell. He has researched Antigen in several fields, including Molecular biology, Receptor and Cell biology. His study connects Ex vivo and Immunology.
Ferry Ossendorp has researched Cytotoxic T cell in several fields, including Epitope and Major histocompatibility complex. He interconnects Cancer, Cancer research, Adjuvant and In vivo in the investigation of issues within Immune system. Ferry Ossendorp works mostly in the field of Antigen presentation, limiting it down to topics relating to MHC class I and, in certain cases, MHC class II.
Ferry Ossendorp mainly investigates Cancer research, Immune system, Immunotherapy, T cell and Tumor microenvironment. His work deals with themes such as PD-L1, Monoclonal antibody and Cancer immunotherapy, which intersect with Cancer research. His studies deal with areas such as Cancer and Antigen as well as Immune system.
His T cell research is multidisciplinary, incorporating elements of Ex vivo, CD8, NFAT, Receptor and Epitope. His research investigates the connection with Epitope and areas like Peptide which intersect with concerns in Antigen presentation. His study in Immune checkpoint is interdisciplinary in nature, drawing from both Cytotoxic T cell, MHC class I and Cytokine.
Ferry Ossendorp mainly focuses on Cancer research, Tumor microenvironment, Immunotherapy, Immune system and T cell. His Cancer research research is multidisciplinary, incorporating perspectives in PD-L1, Antitumor immunity and Checkpoint Blockade Immunotherapy. The Tumor microenvironment study combines topics in areas such as Chemotherapy, Doxorubicin, Chemoimmunotherapy, Monoclonal antibody and In vivo.
He has included themes like Cancer and Clinical evidence in his Immune system study. The concepts of his T cell study are interwoven with issues in Ex vivo, CD8, NFAT, Cancer immunotherapy and Genetically modified mouse. His Cancer immunotherapy research includes elements of Epitope, Ovalbumin, Antigen and Vaccination.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative Tumors
Ferry Ossendorp;Erica Mengedé;Marcel Camps;Rian Filius.
Journal of Experimental Medicine (1998)
Decreased tumor surveillance in perforin-deficient mice.
M. F. Van Den Broek;D. Kagi;F. Ossendorp;R. Toes.
Journal of Experimental Medicine (1996)
CD4 T cells and their role in antitumor immune responses.
René E.M. Toes;Ferry Ossendorp;Rienk Offringa;Cornelis J.M. Melief.
Journal of Experimental Medicine (1999)
Proteasome and peptidase function in MHC-class-I-mediated antigen presentation.
Peter Michael Kloetzel;Ferry Ossendorp.
Current Opinion in Immunology (2004)
Vaccines for established cancer: overcoming the challenges posed by immune evasion.
Sjoerd H. van der Burg;Ramon Arens;Ferry Ossendorp;Thorbald van Hall.
Nature Reviews Cancer (2016)
Therapeutic cancer vaccines
Cornelis J.M. Melief;Thorbald van Hall;Ramon Arens;Ferry Ossendorp.
Journal of Clinical Investigation (2015)
CTLs are targeted to kill β cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope
Ania Skowera;Richard J. Ellis;Ruben Varela-Calviño;Sefina Arif.
Journal of Clinical Investigation (2008)
Efficient Identification of Novel HLA-A * 0201-presented Cytotoxic T Lymphocyte Epitopes in the Widely Expressed Tumor Antigen PRAME by Proteasome-mediated Digestion Analysis
Jan H. Kessler;Nico J. Beekman;Sandra A. Bres-Vloemans;Pauline Verdijk.
Journal of Experimental Medicine (2001)
Reorganization of multivesicular bodies regulates MHC class II antigen presentation by dendritic cells
Monique Kleijmeer;Georg Ramm;Danita Schuurhuis;Janice Griffith.
Journal of Cell Biology (2001)
Autoreactive CD8 T cells associated with β cell destruction in type 1 diabetes
Gabrielle G. M. Pinkse;Odette H. M. Tysma;Cees A. M. Bergen;Michel G. D. Kester.
Proceedings of the National Academy of Sciences of the United States of America (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: